We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The Japan Science and Technology Agency (JST) announced on April 15 that, in
collaboration with Kurume University, it established a venture company, Immunodia,
on April 1.
Advancis Pharmaceutical Corporation, a pharmaceutical
company focused on developing and commercializing novel anti-infective products,
announced it has entered into agreements under which Clonmel Healthcare, Limited
(Clonmel), a subsidiary of STADA Arzneimittel AG (STADA Group), will provide
Advancis with commercial supply of its Amoxicillin PULSYS products currently
being evaluated in Phase III clinical trials.
The FDA recently issued a public health advisory requesting that manufacturers
of certain antipsychotic drugs place black-box warnings on their products to
inform healthcare providers and patients that the drugs can be dangerous when
used off-label to treat behavioral disorders in elderly patients with dementia.
The launch of sanofi-aventis' newest insomnia medication is facing an indefinite
delay after the FDA issued the French firm an approvable letter requesting additional
information about the drug.
A Philadelphia jury has cleared Wyeth Pharmaceuticals of liability in four personal
injury cases involving the diet drug combination fen-phen, which was pulled
from the market in 1997 following claims the product caused heart damage.
The drug industry has high hopes for its proposed electronic drug-labeling system,
which can provide pharmacies with labeling changes in real-time and do away
with the odd-sized paper labels that now must be affixed to the sides of medicine
bottles.
AlphaVax announced that it has received a significant new vaccine development
grant from the National Institute of Allergy and Infectious Diseases (NIAID)
of the National Institutes of Health (NIH), an agency of the U.S. Department
of Health and Human Services.
Millenia Hope, a Biotech Corporation, announced the addition of Jacky Quan to
the board of directors. Quan will also be taking the founding position of President
of Millenia Hope, Hong Kong.
Sumitomo Chemical has agreed with Inabata & Co. to acquire a part of Inabata's
voting stocks of Sumitomo Pharmaceuticals. When materialized, Sumitomo Chemical
will increase its share in Sumitomo Pharmaceuticals to 85.7 percent.